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Background
Glycoproteins are important for cellular processes including cell 
recognition and protein cellular quality control [1]. They are estimated to 
make up > 50% of proteins [2]. Additionally, they may be the key to 
unlocking new therapeutic vaccines and cancer immunotherapy 
treatments [3]. However, glycoproteins remain understudied due to the 
difficulty of obtaining homogenous samples. A recently published 
glycoligation method may be a breakthrough if improved [1]. 
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Conclusion
All four Asp(NBT) containing
peptides were successfully
synthesized without evidence of
aspartimide formation. Analysis 
revealed secondary peaks 
containing peptide minus Val for 
1-3 and peptide minus Ser for 4.
These are consistent with control 
peptides and are likely a product
of incomplete coupling.
The main objective of this study was producing and 
analyzing four peptides containing Asp(NBT) to test if 
Asp(NBT) can work in place of  Asp(S-Trt) and avoid 
aspartimide formation. This was accomplished using 
the method of Solid Phase Peptide Synthesis [5].
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Next Steps
The peptides synthesized in this study have been sent to the 
Garner lab at Washington State where the proposed method 
for turning Asp(NBT) peptide into glycoligation ready 
aspartic thioacid peptide will be tested. If successful, the 
amber suppression technique will be used to genetically 
encode proteins containing Asp(NBT) for use in the first 
protein glycosylation attempt using the new glycoligation 
method [7]. 
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mH+
Calc.
(g/mol)
mH+
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(g/mol)
1. VNKDVTS-NH2 8.24 761.85 761.3
2. VNKDATS-NH2 5.04 734.78 733.3
3. VNKDGTS-NH2 5.55* 720.75 719.3
4. GQDDTSQTSSPS-NH2 6.98 1209.16 1208.9
Molecular Weight: 911.00
Molecular Weight: 939.06
Molecular Weight: 896.98
Molecular Weight: 1387.35
Control peptides were 
synthesized using aspartate in 
place of Asp(NBT).
3. VNK-Asp(NBT)-GTS-NH2
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Glycosylation Glycoligation
Gradient elution 5 – 50% Acetonitrile. 214 nm 
Gradient elution 0 – 50% Acetonitrile. 214 nm
The glycoligation method required peptides to be created using solid 
phase peptide synthesis using trityl protected aspartic thioester (Asp(S-
Trt)) residues at intended ligation sites [4].However, these thioacid
precursors can induce an unwanted aspartimide formation [4]. A method 
to eliminate the aspartimide formation must be discovered to improve 
the glycoligation strategy. Aspartyl nitrobenzothiazine (Asp(NBT)) should 
be resistant to aspartimide formation, and work in place of Asp(S-Trt).
Acknowledgments
The project described was supported by a SURF award 
provided by the University of Idaho Office of Undergraduate 
Research.
Other support provided by Peptidaho Research Consortium
Thank you to Gonzaga University for use of the Waters LCT 
Premier TOF electrospray mass spectrometer funded by NSF 
CRIF:MU grant #0741868
Thank you to the Odom Corporation as well as Laughing Dog 
and No Li Breweries for the printing of this poster.
Thank you to the Harbor Center for providing lab space.
D.C. and P.G. work funded by NSF CHE 1149327
1-3 were chosen due to varying levels of 
aspartimide formation found using the Asp(S-Trt) 
versions [4]. 4 was chosen due to its medical 
significance. The glycosylated and GPI anchored 
version of 4 is the antigen to the therapeutic antibody 
Alemtuzumab, a commonly used drug to treat chronic 
lymphocytic leukemia [6]
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